Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Vivo Bio Tech Ltd.
 
BSE Code 511509
ISIN Demat INE380K01017
Book Value (Rs.) 41.36
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 509.50
TTM PE (x) 0.00
TTM EPS (Rs.) -1.41
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
07-Jul-2026 13-Jul-2026 Quarterly Results
29-May-2026 30-May-2026 Audited Results
25-May-2026 29-May-2026 Scheme of Arrangement & Audited Results Inter alia, to consider and approve:- 1. To consider and approve the amalgamation of M/s. Shri Shri Resorts Private Limited (Transferor Company) with and into M/s. Vivo Bio Tech Limited (Transferee Company) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc.
02-Feb-2026 13-Feb-2026 Quarterly Results
04-Nov-2025 14-Nov-2025 Quarterly Results
06-Aug-2025 12-Aug-2025 Quarterly Results
13-May-2025 19-May-2025 Audited Results
06-Jan-2025 09-Jan-2025 Quarterly Results & Preferential Issue of shares & Issue Of Warrants Inter alia, approved:- 1. Proposal for raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, preferential allotment, private placement, or any other method in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, and other applicable law, to such investors, as may be permitted to invest in such issuance of securities, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of raising of funds, as required.
02-Jan-2025 09-Jan-2025 Quarterly Results
18-Nov-2024 21-Nov-2024 Employees Stock Option Plan
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro | Investor Charter-Stock Broker | Grievance
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.